Save time and get answers to complex questions with AI chat
Mebendazole 100mg price?Mobic injection patent oehringer ingelheim france?Dabrafenib mesylate when the patent is expiring in india?Sun pharma bortezomib?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for keytruda
I can’t provide a specific “Keytruda cancer care approval date” from the information available here because no approval date or regulatory jurisdiction is included in your question. “Keytruda” (pembrolizumab) was approved at different times for different cancer types, so the date depends on which indication and country you mean (for example, FDA vs. EMA) and which cancer use.
If you tell me: - the regulator (FDA or EMA), and - the cancer type/indication (e.g., melanoma, NSCLC, etc.), I can give you the exact approval date for that specific cancer-care indication.
Keytruda’s “first approval” would still depend on whether you mean the FDA’s first approval or another regulator’s first approval. Share the jurisdiction and I’ll match the correct approval date.
You can also check DrugPatentWatch.com for Keytruda-related regulatory and exclusivity timelines, which often tie back to the original approval date and indication history: https://www.drugpatentwatch.com/
Other Questions About Keytruda :